Optimizing Therapy With Radium 223 For Prostate Cancer

Joe O’Sullivan, MD, FRCPI, FFRRCSI, FRCR; Chris Parker, MD, FRCR, MRCP; and Bertrand Tombal, MD, PhD, share their insights on the ways to optimize radium-223 therapy for metastatic castration-resistant prostate cancer.

  • Optimizing Therapy with Radium-223 for Prostate Cancer ( Download)
  • Timing and Optimization of Radium 223 in Castration Resistant Prostate Cancer ( Download)
  • Bone-Targeted Therapy for Prostate Cancer: Radium-223 ( Download)
  • Radium-223 and Metastatic Prostate Cancer ( Download)
  • The Role of Therapeutic Layering in Optimizing Treatment for Patients with Prostate Cancer ( Download)
  • Optimizing Outcomes in Advanced Prostate Cancer ( Download)
  • Bone-migrated prostate cancer and Radium-223 therapy ( Download)
  • What Combination Drugs with Radium 223 Are Best for Treating Prostate Cancer ( Download)
  • Patient Monitoring during Radium-223 Treatment in Prostate Cancer ( Download)
  • Dr. Morris on Challenges of Radium-223 Treatment in Prostate Cancer ( Download)
  • Dr. Saad on Radium-223 for Prostate Cancer ( Download)
  • Radium-223 Alone and with Other Agents for Prostate Cancer ( Download)
  • Dr. Morris on Mechanism of Action for Radium-223 ( Download)
  • Combining Radium-223 with Other Therapies in Prostate Cancer ( Download)
  • Radium-223 in Advanced Disease ( Download)